The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome
Open accessAbstract
Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder that is characterized by dramatic premature aging and accelerated cardiovascular disease. HGPS is almost always caused by a de novo point mutation in the lamin A gene ( LMNA ) that activates a cryptic splice donor site, producing a truncated mutant protein termed “progerin.” WT prelamin A is anchored to the nuclear envelope by a farnesyl isoprenoid lipid. Cleavage of the terminal 15 aa and the farnesyl group releases mature lamin A from this tether. In contrast, this cleavage site is deleted in progerin. We hypothesized that retention of the farnesyl group causes progerin to become permanently anchored in the nuclear membrane, disrupting proper nuclear scaffolding and causing the characteristic nuclear blebbing seen in HGPS cells. Also, we hypothesized that blocking farnesylation would decrease progerin toxicity. To test this hypothesis, the terminal CSIM sequence in progerin was mutated to SSIM, a sequence that cannot be farnesylated. SSIM progerin relocalized from the nuclear periphery into nucleoplasmic aggregates and produced no nuclear blebbing. Also, blocking farnesylation of authentic progerin in transiently transfected HeLa, HEK 293, and NIH 3T3 cells with farnesyltransferase inhibitors (FTIs) restored normal nuclear architecture. Last, treatment of both early- and late-passage human HGPS fibroblasts with FTIs resulted in significant reductions in nuclear blebbing. Our results suggest that treatment with FTIs represents a potential therapy for patients with HGPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tests for Linear Trends in Proportions and Frequencies
Armitage, P. (1955) · Biometrics · doi:10.2307/3001775 · Cited by 2,071
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., et al. (2003) · Nature · doi:10.1038/nature01629 · Cited by 1,990
Self-citationLamin a truncation in Hutchinson-Gilford progeria
De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C. L., Munnich, A., Le Merrer, M., et al. (2003) · Science · doi:10.1126/science.1084125 · Cited by 1,346
Loss of a-Type Lamin Expression Compromises Nuclear Envelope Integrity Leading to Muscular Dystrophy
Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C. L., & Burke, B. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.913 · Cited by 1,211
Goldman, R. D., Shumaker, D. K., Erdos, M. R., Eriksson, M., Goldman, A. E., Gordon, L. B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402943101 · Cited by 1,103
Self-citationK- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors
Whyte, D. B., Kirschmeier, P., Hockenberry, T. N., Nunez-Oliva, I., James, L., Catino, J. J., Bishop, W. R., & Pai, J.-K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14459 · Cited by 884
The nuclear lamina comes of age
Gruenbaum, Y., Margalit, A., Goldman, R. D., Shumaker, D. K., & Wilson, K. L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1550 · Cited by 834
Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides
Reiss, Y., Goldstein, J. L., Seabra, M. C., Casey, P. J., & Brown, M. S. (1990) · Cell · doi:10.1016/0092-8674(90)90242-7 · Cited by 817
Nuclear lamins: building blocks of nuclear architecture
Goldman, R. D., Gruenbaum, Y., Moir, R. D., Shumaker, D. K., & Spann, T. P. (2002) · Genes & Development · doi:10.1101/gad.960502 · Cited by 586
Pendás, A. M., Zhou, Z., Cadiñanos, J., Freije, J. M. P., Wang, J., Hultenby, K., Astudillo, A., Wernerson, A., Rodríguez, F., Tryggvason, K., et al. (2002) · Nature Genetics · doi:10.1038/ng871 · Cited by 554
Scaffidi, P., & Misteli, T. (2005) · Nature Medicine · doi:10.1038/nm1204 · Cited by 553
Röber, R.-A., Weber, K., & Osborn, M. (1989) · Development · doi:10.1242/dev.105.2.365 · Cited by 533
Bergo, M. O., Gavino, B., Ross, J., Schmidt, W. K., Hong, C., Kendall, L. V., Mohr, A., Meta, M., Genant, H., Jiang, Y., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192460799 · Cited by 451
Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia
Agarwal, A. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg213 · Cited by 401
The Hutchinson-Gilford progeria syndrome
DeBusk, F. L. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80229-4 · Cited by 396
Navarro, C. L., De Sandre-Giovannoli, A., Bernard, R., Boccaccio, I., Boyer, A., Geneviève, D., Hadj-Rabia, S., Gaudy-Marqueste, C., Smitt, H. S., Vabres, P., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh265 · Cited by 380
Direct Demonstration of Geranylgeranylation and Farnesylation of Ki-Ras in Vivo
Rowell, C. A., Kowalczyk, J. J., Lewis, M. D., & Garcia, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14093 · Cited by 368
Mammalian Prenylcysteine Carboxyl Methyltransferase Is in the Endoplasmic Reticulum
Dai, Q., Choy, E., Chiu, V., Romano, J., Slivka, S. R., Steitz, S. A., Michaelis, S., & Philips, M. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15030 · Cited by 296
Isoprenylation is required for the processing of the lamin A precursor.
Beck, L. A., Hosick, T. J., & Sinensky, M. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.5.1489 · Cited by 228
Hutchinson, J. (1886) · Journal of the Royal Society of Medicine · doi:10.1177/095952878606900127 · Cited by 216
Fong, L. G., Ng, J. K., Meta, M., Coté, N., Yang, S. H., Stewart, C. L., Sullivan, T., Burghardt, A., Majumdar, S., Reue, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408558102 · Cited by 209
Zhang, F. L., Kirschmeier, P., Carr, D., James, L., Bond, R. W., Wang, L., Patton, R., Windsor, W. T., Syto, R., Zhang, R., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10232 · Cited by 197
The laminopathies: nuclear structure meets disease
Mounkes, L., Kozlov, S., Burke, B., & Stewart, C. L. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00058-3 · Cited by 195
Hennekes, H., & Nigg, E. A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.4.1019 · Cited by 181
Searching for the elusive targets of farnesyltransferase inhibitors
Sebti, S. M., & Der, C. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1234 · Cited by 169
Self-citationResistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells.
James, G., Goldstein, J. L., & Brown, M. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4454 · Cited by 158
Novel Tricyclic Inhibitors of Farnesyl Protein Transferase
Bishop, W. R., Bond, R. W., Petrin, J., Wang, L., Patton, R., Doll, R. J., Njoroge, G. F., Catino, J. J., Schwartz, J. L., Windsor, W. T., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30611 · Cited by 153
Farnesyltransferase inhibitors: promises and realities
Cox, A. D. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00181-9 · Cited by 141
Self-citationEdible vaccines: not quite ready for prime time
Bonetta, L. P. (2002) · Nature Medicine · doi:10.1038/nm0202-94 · Cited by 121
Cardiovascular abnormalities in progeria. Case report and review of the literature.
Baker, P. B., Baba, N., & Boesel, C. P. (1981) · PubMed · Cited by 105
Farnesyltransferase inhibitors as anticancer agents: critical crossroads.
Doll, R. J., Kirschmeier, P. T., & Bishop, W. R. (2004) · PubMed · Cited by 80
Broers, J. L. V., Hutchison, C., & Ramaekers, F. C. S. (2004) · The Journal of Pathology · doi:10.1002/path.1655 · Cited by 73
Hutchinson-Guilford progeria syndrome
Sarkar, P. R., & Shinton, R. A. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.907.312 · Cited by 71
Cited by
Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging
Shumaker, D. K., Dechat, T., Kohlmaier, A., Adam, S. A., Bozovsky, M. R., Erdos, M. R., Eriksson, M., Goldman, A. E., Khuon, S., Collins, F. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602569103 · Cited by 791
Self-citationHuman iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Phenotype and Course of Hutchinson–Gilford Progeria Syndrome
Merideth, M. A., Gordon, L. B., Clauss, S., Sachdev, V., Smith, A. C. M., Perry, M. B., Brewer, C. C., Zalewski, C., Kim, H. J., Solomon, B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706898 · Cited by 743
Self-citation“Laminopathies”: A wide spectrum of human diseases
Worman, H. J., & Bonne, G. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.028 · Cited by 661
Nuclear Lamins: Laminopathies and Their Role in Premature Ageing
Broers, J. L. V., Ramaekers, F. C. S., Bonne, G., Yaou, R. B., & Hutchison, C. J. (2006) · Physiological Reviews · doi:10.1152/physrev.00047.2005 · Cited by 578
Metadata
- Authors
- Capell, B. C., Erdos, M. R., Madigan, J. P., Fiordalisi, J. J., Varga, R., Conneely, K. N., Gordon, L. B., Der, C. J., Cox, A. D., & Collins, F. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-08-29
- Volume
- 102
- Issue
- 36
- Pages
- 12879-12884
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2141334538
- Cited by
- 398
- References
- 33
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.